739 related articles for article (PubMed ID: 29626281)
1. Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study.
Badreldin H
J Thromb Thrombolysis; 2018 Jul; 46(1):16-21. PubMed ID: 29626281
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of anticoagulation selection for acute venous thromboembolism.
Badreldin H; Nichols H; Rimsans J; Carter D
J Thromb Thrombolysis; 2017 Jan; 43(1):74-78. PubMed ID: 27592341
[TBL] [Abstract][Full Text] [Related]
3. Initiation of direct oral anticoagulants versus warfarin for venous thromboembolism: impact on time to hospital discharge.
Basto AN; Fewel NP; Vo K; Stock EM; Ta M
J Thromb Thrombolysis; 2018 Jan; 45(1):51-55. PubMed ID: 29086244
[TBL] [Abstract][Full Text] [Related]
4. Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location.
Janczak DT; Mimier MK; McBane RD; Kamath PS; Simmons BS; Bott-Kitslaar DM; Lenz CJ; Vargas ER; Hodge DO; Wysokinski WE
Mayo Clin Proc; 2018 Jan; 93(1):40-47. PubMed ID: 29217335
[TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
Perales IJ; San Agustin K; DeAngelo J; Campbell AM
Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
[No Abstract] [Full Text] [Related]
6. All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.
Roetker NS; Lutsey PL; Zakai NA; Alonso A; Adam TJ; MacLehose RF
Thromb Haemost; 2018 Sep; 118(9):1637-1645. PubMed ID: 30103250
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
Rollins BM; Silva MA; Donovan JL; Kanaan AO
Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
[TBL] [Abstract][Full Text] [Related]
8. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
[TBL] [Abstract][Full Text] [Related]
9. Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan.
Nakamura M; Yamada N; Ito M
J Atheroscler Thromb; 2017 Jun; 24(6):560-565. PubMed ID: 28392512
[TBL] [Abstract][Full Text] [Related]
10. Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
Medina A; Raskob G; Ageno W; Cohen AT; Brekelmans MPA; Chen CZ; Grosso MA; Mercuri MF; Segers A; Verhamme P; Vanassche T; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
Thromb Haemost; 2017 Dec; 117(12):2406-2414. PubMed ID: 29212128
[TBL] [Abstract][Full Text] [Related]
11. New oral anticoagulants for the treatment of venous thromboembolism.
Agnelli G; Becattini C; Franco L
Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
[TBL] [Abstract][Full Text] [Related]
12. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.
Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
J Med Econ; 2015 Jun; 18(6):399-409. PubMed ID: 25586203
[TBL] [Abstract][Full Text] [Related]
13. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
Alzghari SK; Seago SE; Garza JE; Hashimie YF; Baty KA; Evans MF; Shaver C; Herrington JD
J Oncol Pharm Pract; 2018 Oct; 24(7):494-500. PubMed ID: 28714376
[TBL] [Abstract][Full Text] [Related]
14. Is it reasonable to use a lower DOACs dose in some patients with VTE? Yes.
Imberti D; Mastroiacovo D
Intern Emerg Med; 2017 Aug; 12(5):561-563. PubMed ID: 28647891
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation prescribing patterns in patients with cancer.
Xiang E; Ahuja T; Raco V; Cirrone F; Green D; Papadopoulos J
J Thromb Thrombolysis; 2018 Jan; 45(1):89-98. PubMed ID: 29052104
[TBL] [Abstract][Full Text] [Related]
16. Drug Treatment of Venous Thromboembolism in the Elderly.
Boey JP; Gallus A
Drugs Aging; 2016 Jul; 33(7):475-90. PubMed ID: 27255713
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
18. Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.
Imberti D; Pomero F; Benedetti R; Fenoglio L
Intern Emerg Med; 2016 Oct; 11(7):895-900. PubMed ID: 27550399
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants].
Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T
Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024
[TBL] [Abstract][Full Text] [Related]
20. Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies.
Deitelzweig S; Farmer C; Luo X; Vo L; Li X; Hamilton M; Horblyuk R; Ashaye A
Curr Med Res Opin; 2017 Sep; 33(9):1583-1594. PubMed ID: 28644048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
